Nat Turner, co-founder and CEO of Flatiron Health, discusses how oncologists use data to assist them in meeting the requirements in new payment models.
Nat Turner, co-founder and CEO of Flatiron Health, discusses how oncologists use data to assist them in meeting the requirements in new payment models.
Transcript (slightly modified)
How are oncologists using data to help them meet the requirements in new payment models?
There are some simple things and some complicated things. The simplest ones—our software has the care plan built-in, so the IOM [Institute of Medicine] care plan physician doesn’t have to think about it. It auto-populates an OncoEMR, you can print it right there, the patient can be in the room, and done. A lot of analytics—getting a little more complicated but very important—analytics around how many patients do I have that are potentially eligible for the episode, which of my physicians are appropriately completing the care plan for the appropriate patients?
Getting a little more sophisticated quality measures—these are very complicated measures, some of them are easy and some are pretty hard. It takes a lot of manual work if you are going to do it on your own, to be compliant and provide the data. Some of them you have to track and some of them Medicare tracks for you. We help you in both.
So, the software is basically automating the quality measure process and moving it to the more sophisticated realm is more analytics around: what is your cost of care? What are the opportunities to implement programs that could reduce cost? For example, in hospital admissions or ER visits—more deeper analytics to help you transform your practice. Those are kind of the levels.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More